MINNEAPOLIS--(BUSINESS WIRE)--May 17, 2006--Medtronic, Inc., (NYSE:MDT - News) today announced United States Food and Drug Administration approval of the Medtronic Concerto(TM)/Virtuoso(TM) line of implantable cardiac devices, Medtronic’s next generation of cardiac rhythm disease management products. The approval coincides with Heart Rhythm 2006, the Heart Rhythm Society’s 27th Annual Scientific Sessions - the pre-eminent gathering of medical professionals from across the globe who specialize in the heart’s rhythms and electrical function. Market availability of these devices will follow in June 2006.
